SCHEMBL6169100

SCHEMBL6169100

CCc1ccnc(C(C)=O)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
PRKCI P41743 1/20 0.34
KDM4E B2RXH2 2/20 0.33
CYP1A2 P05177 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
DYRK1A Q13627 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
HPGD P15428 1/20 0.33
PTGS2 P35354 1/20 0.33
CLCN2 P51788 1/20 0.32
AURKA O14965 1/20 0.32
MAP4K4 O95819 1/20 0.32
PAK4 O96013 1/20 0.32
ABL1 P00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27554810 0.82 GSK3B (0.38) ALDH1A1MAPTL3MBTL1PRKCIKDM4E
Bromide SCHEMBL6169293 0.81 GSK3B (0.37) ALDH1A1MAPTL3MBTL1PRKCINPC1
SCHEMBL6171233 0.79 KDM4E (0.42) PDE3BPDE3AALDH1A1MAPTPRKCI
SCHEMBL26598072 0.78 KDM4E (0.41) PDE3BPDE3AALDH1A1MAPTL3MBTL1
SCHEMBL9696604 0.77 PDE3B (0.40) PDE3BPDE3AALDH1A1MAPTL3MBTL1
SCHEMBL13180249 0.76 GABRA1 (0.37) ALDH1A1MAPTL3MBTL1KDM4ECYP1A2
SCHEMBL5020020 0.75 BUB1 (0.34) PDE3BPDE3AALDH1A1MAPTL3MBTL1
SCHEMBL1135139 0.75 KDM4E (0.37) ALDH1A1MAPTL3MBTL1KDM4ENPC1
SCHEMBL6109973 0.74 KDM4E (0.50) PDE3BPDE3AALDH1A1MAPTL3MBTL1
SCHEMBL28012435 0.74 PDE3B (0.41) PDE3BPDE3AALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
CN-1284064-A 2,3-substituted indole compounds as cox-2 inhibitors PFIZER PHARMA (US) 2001-02-14 CN disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed